Physician profile
Cesar Brito
NPI 1801861661
$9,840.28
in general payments reported to CMS, 2019-2025
38 companies · $2,477 in 2025
The $2,477 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,057 · 2020: $98.53 · 2021: $451 · 2022: $1,322 · 2023: $2,029 · 2024: $1,405 · 2025: $2,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,846 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Education: $48.25 · Travel and Lodging: $17.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,845.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Education | $48.25 |
| Travel and Lodging | $17.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,677.72 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $688.66 | 2022-2025 | Pylarify |
| Abbvie INC. | $519.54 | 2021-2025 | Avycaz, Lupron Depot, Dalvance |
| Calyxo, INC. | $414.39 | 2024-2025 | Cvac Aspiration System |
| Pfizer INC. | $383.12 | 2019-2025 | |
| Procept Biorobotics Corporation | $366.04 | 2022-2025 | Aquabeam Robotic System |
| Coloplast Corp | $348.24 | 2019-2025 | Speedicath, Luja Coude |
| Janssen Biotech, INC. | $332.61 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $278.10 | 2019-2024 | Ams 700, Rezum Generator |
| Blue Earth Diagnostics | $245.29 | 2019-2025 | Posluma |
| Sumitomo Pharma America, INC. | $244.59 | 2024-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $184.17 | 2022-2025 | |
| Urogen Pharma, INC. | $180.61 | 2020-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $167.67 | 2023-2024 | Prolaris |
| Novartis Pharmaceuticals Corporation | $158.21 | 2024-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $157.92 | 2022-2025 | Keytruda, Keytruda Qlex, Lynparza |
| 180 Medical, INC. | $154.48 | 2019-2023 | Gentlecath Glide |
| Dendreon Pharmaceuticals LLC | $149.09 | 2019-2024 | Provenge |
| Angiodynamics, INC. | $140.91 | 2025 | Nanoknife |
| C. R. Bard, INC. & Subsidiaries | $127.98 | 2019-2025 | Bard Urinary Drainage Bag |
| Astellas Pharma US INC | $126.29 | 2021-2025 | Xtandi, Myrbetriq |
| Antares Pharma, INC. | $86.02 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Ambu INC. | $80.98 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $72.62 | 2021-2025 | Imfinzi |
| Profound Medical Corp. | $71.10 | 2025 | Tulsa-Pro |
| Ferring Pharmaceuticals INC. | $68.14 | 2024-2025 | Adstiladrin |
| Endo USA, INC. | $66.22 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $62.50 | 2023-2025 | Itind System |
| Teleflex LLC | $56.29 | 2021-2025 | Urolift |
| Endo Pharmaceuticals INC. | $44.72 | 2023-2024 | Aveed, Xiaflex |
| Amgen INC. | $41.42 | 2021-2022 | |
| Axonics, INC. | $35.17 | 2022-2023 | Axonics |
| Alnylam Pharmaceuticals INC. | $26.53 | 2025 | Givlaari |
| Tempus Ai, INC | $20.94 | 2024 | |
| Inspire Medical Systems, INC. | $18.52 | 2025 | Inspire |
| Verity Pharmaceuticals INC. | $16.75 | 2022 | |
| Baxter Healthcare | $14.87 | 2023 | Tisseel |
| Biotissue Holdings INC. | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Brito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.